c ebpβ-lip drug C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module c ebpβ-lip drug Facts Continuous

Constantin A, Loubet-Lescoulie P, Lambert N, Yassine-Diab B, Abbal M, Mazieres B, de Preval C, Cantagrel A: Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction

The conserved AAA-ATPase Msp1 confers organelle specificity to tail-anchored proteins

Food and Drug Administration doesnt monitor the manufacture or sale of supplements or herbs

No metabolic tax

Incorporation of protein flexibility and conformational energy penalties in docking screens to improve ligand discovery